• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法尼基焦磷酸合酶的抑制作用减弱高糖诱导的血管平滑肌细胞增殖。

Inhibition of farnesyl pyrophosphate synthase attenuates high glucose‑induced vascular smooth muscle cells proliferation.

作者信息

Chen Guo-Ping, Zhang Xiao-Qin, Wu Tao, Han Jie, Ye Dan

机构信息

Department of Endocrinology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.

Department of Respirology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China.

出版信息

Mol Med Rep. 2017 May;15(5):3153-3160. doi: 10.3892/mmr.2017.6360. Epub 2017 Mar 23.

DOI:10.3892/mmr.2017.6360
PMID:28339090
Abstract

The proliferation of vascular smooth muscle cells (VSMCs) is one of the main features of atherosclerosis accelerated by hyperglycemia. Our previous studies found that farnesyl pyrophosphate synthase (FPPS, EC 2.5.1.10), an essential enzyme in the mevalonate pathway, was upregulated in aorta media from diabetic mice along with the process of atherosclerosis. However, the exact role of FPPS in high glucose‑induced proliferation of VSMCs is largely unclear. In our study, we found that alendronate (an FPPS inhibitor) attenuated diabetic accelerated atherosclerosis in vivo and suppressed high glucose‑induced VSMCs proliferation in vitro. Moreover, in aorta from streptozotocin (STZ)‑induced diabetic mice, 16‑week treatment of alendronate decreased the activation of small GTPase (Ras, RhoA, and Rac1), but had no effect on the expression of cystathionine γ‑lyase (CSE), the pivotal H2S‑producing enzyme. Meanwhile, in VSMCs cultured in high glucose‑containing media, alendronate remarkably decreased total CoQ content, increased the H2S level, depressed small GTPases (Ras, RhoA, and Rac1) activation, but yet had no effect on expression of CSE. In conclusion, FPPS inhibition by alendronate attenuated the high glucose‑induced proliferation of VSMCs both in vivo and in vitro, probably though depressing H2S metabolism and suppressing small GTPases (Ras, RhoA, and Rac1) activation.

摘要

血管平滑肌细胞(VSMCs)的增殖是高血糖加速动脉粥样硬化的主要特征之一。我们之前的研究发现,法尼基焦磷酸合酶(FPPS,EC 2.5.1.10)是甲羟戊酸途径中的一种关键酶,在糖尿病小鼠的主动脉中膜中随着动脉粥样硬化进程而上调。然而,FPPS在高糖诱导的VSMCs增殖中的确切作用仍不清楚。在我们的研究中,我们发现阿仑膦酸钠(一种FPPS抑制剂)在体内减轻了糖尿病加速的动脉粥样硬化,并在体外抑制了高糖诱导的VSMCs增殖。此外,在链脲佐菌素(STZ)诱导的糖尿病小鼠的主动脉中,16周的阿仑膦酸钠治疗降低了小GTP酶(Ras、RhoA和Rac1)的激活,但对关键的硫化氢产生酶胱硫醚γ-裂解酶(CSE)的表达没有影响。同时,在含高糖培养基中培养的VSMCs中,阿仑膦酸钠显著降低了总辅酶Q含量,提高了硫化氢水平,抑制了小GTP酶(Ras、RhoA和Rac1)的激活,但对CSE的表达没有影响。总之,阿仑膦酸钠抑制FPPS在体内和体外均减轻了高糖诱导的VSMCs增殖,可能是通过抑制硫化氢代谢和抑制小GTP酶(Ras、RhoA和Rac1)的激活来实现的。

相似文献

1
Inhibition of farnesyl pyrophosphate synthase attenuates high glucose‑induced vascular smooth muscle cells proliferation.法尼基焦磷酸合酶的抑制作用减弱高糖诱导的血管平滑肌细胞增殖。
Mol Med Rep. 2017 May;15(5):3153-3160. doi: 10.3892/mmr.2017.6360. Epub 2017 Mar 23.
2
Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process.糖尿病小鼠增殖性血管平滑肌中甲羟戊酸途径的改变:在高糖诱导的动脉粥样硬化过程中的可能作用。
J Diabetes Res. 2015;2015:379287. doi: 10.1155/2015/379287. Epub 2015 Mar 30.
3
Calcium sensing receptor regulating smooth muscle cells proliferation through initiating cystathionine-gamma-lyase/hydrogen sulfide pathway in diabetic rat.钙敏感受体通过启动糖尿病大鼠体内的胱硫醚-γ-裂解酶/硫化氢途径来调节平滑肌细胞增殖。
Cell Physiol Biochem. 2015;35(4):1582-98. doi: 10.1159/000373973. Epub 2015 Mar 18.
4
Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats.RhoA异戊二烯化的改变改善自发性高血压大鼠的心脏和血管重塑。
Cell Physiol Biochem. 2016;39(1):229-41. doi: 10.1159/000445619. Epub 2016 Jun 24.
5
Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced fibrotic responses in vascular smooth muscle cells.法尼基焦磷酸合酶的抑制作用减弱血管平滑肌细胞中血管紧张素II诱导的纤维化反应。
Int J Mol Med. 2015 Jun;35(6):1767-72. doi: 10.3892/ijmm.2015.2166. Epub 2015 Apr 2.
6
Alpha-lipoic acid regulates the autophagy of vascular smooth muscle cells in diabetes by elevating hydrogen sulfide level.α-硫辛酸通过提高硫化氢水平调节糖尿病血管平滑肌细胞的自噬。
Biochim Biophys Acta Mol Basis Dis. 2018 Nov;1864(11):3723-3738. doi: 10.1016/j.bbadis.2018.09.005. Epub 2018 Sep 7.
7
Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.法呢基焦磷酸合酶抑制剂可减轻血管紧张素Ⅱ诱导的体内心肌肥厚和纤维化。
Int J Biochem Cell Biol. 2013 Mar;45(3):657-66. doi: 10.1016/j.biocel.2012.12.016. Epub 2012 Dec 29.
8
Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation.硫化氢通过上调蛋白质 S-亚硝基化来抑制动脉粥样硬化的发展。
Biomed Pharmacother. 2016 Oct;83:466-476. doi: 10.1016/j.biopha.2016.07.003. Epub 2016 Jul 16.
9
Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling.法呢基焦磷酸合酶抑制剂可改善压力超负荷诱导的慢性心脏重构。
Sci Rep. 2016 Dec 23;6:39186. doi: 10.1038/srep39186.
10
DR1 activation promotes vascular smooth muscle cell apoptosis via up-regulation of CSE/H S pathway in diabetic mice.DR1 激活通过上调糖尿病小鼠中 CSE/H S 通路促进血管平滑肌细胞凋亡。
FASEB J. 2022 Jan;36(1):e22070. doi: 10.1096/fj.202101455R.

引用本文的文献

1
Targeting Small GTPases and Their Prenylation in Diabetes Mellitus.靶向糖尿病中小 GTP 酶及其异戊烯化修饰
J Med Chem. 2021 Jul 22;64(14):9677-9710. doi: 10.1021/acs.jmedchem.1c00410. Epub 2021 Jul 8.
2
Geranylgeranyl Transferase-I Knockout Inhibits Oxidative Injury of Vascular Smooth Muscle Cells and Attenuates Diabetes-Accelerated Atherosclerosis.香叶基香叶基转移酶-I 敲除抑制血管平滑肌细胞氧化损伤并减轻糖尿病加速的动脉粥样硬化。
J Diabetes Res. 2020 Aug 10;2020:7574245. doi: 10.1155/2020/7574245. eCollection 2020.
3
MicroRNA‑125a‑mediated regulation of the mevalonate signaling pathway contributes to high glucose‑induced proliferation and migration of vascular smooth muscle cells.
微小 RNA-125a 通过调节甲羟戊酸信号通路促进高糖诱导的血管平滑肌细胞增殖和迁移。
Mol Med Rep. 2020 Jul;22(1):165-174. doi: 10.3892/mmr.2020.11077. Epub 2020 Apr 16.
4
Hydrogen Sulfide (HS)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases.硫化氢(HS)释放化合物:在心血管疾病中的治疗潜力
Front Pharmacol. 2018 Sep 21;9:1066. doi: 10.3389/fphar.2018.01066. eCollection 2018.